You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

List of Excipients in Branded Drug GOOD NEIGHBOR PHARMACY ALL DAY ALLERGY D


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing GOOD NEIGHBOR PHARMACY ALL DAY ALLERGY D

Excipient Strategy and Commercial Opportunities for GOOD NEIGHBOR PHARMACY ALL DAY ALLERGY D

Last updated: March 1, 2026

What is the excipient landscape for GOOD NEIGHBOR PHARMACY ALL DAY ALLERGY D?

The product is an oral antihistamine tablet marketed as a 24-hour allergy relief medication. The formulation relies on specific excipients to ensure stability, bioavailability, and patient compliance.

Key excipients likely include:

  • Diluent/Fillers: Microcrystalline cellulose (MCC), lactose monohydrate.
  • Disintegrants: Croscarmellose sodium, sodium starch glycolate.
  • Binders: Povidone (PVP), hydroxypropyl methylcellulose (HPMC).
  • Lubricants: Magnesium stearate, stearic acid.
  • Glidants: Colloidal silica.
  • Colorants and Flavorings: Titanium dioxide, FD&C dyes, flavoring agents.

The choice hinges on proven safety profiles, manufacturing stability, and patient acceptability. These excipients influence drug dissolution, shelf life, and taste-masking.

How does excipient optimization improve product performance and marketability?

Optimizing excipients can enhance bioavailability, reduce formulation costs, and improve patient experience. For example:

  • Disintegrants accelerate drug release, critical for a quick onset.
  • Binders stabilize the tablet, extending shelf life.
  • Flavorings improve compliance, especially among children or sensitive populations.

In product differentiation, excipient selection can support claim substantiation. For instance, using non-GMO or gluten-free ingredients appeals to niche markets.

What are the commercial opportunities related to excipient strategies?

  1. Market Expansion via Excipient Innovation

    Developing formulations with allergen-free excipients (e.g., lactose-free, gluten-free) aligns with gluten-sensitive or lactose-intolerant consumers. This could open access to new patient segments, especially in markets with high prevalence of food allergies or intolerances.

  2. Enhanced Shelf Stability and Reduced Cost

    Using excipients with natural stabilizing properties or better moisture barriers may extend shelf life. Longer shelf life reduces logistical costs and waste. Cost-efficient excipients, such as MCC over branded binders, can improve profit margins.

  3. Formulation Differentiation for Patent Protection

    Innovating in excipient combinations—for example, novel disintegrant blends or sustained-release excipients—can create proprietary formulations. These can enable patent filings, preventing generic entry and commanding premium prices.

  4. Ease of Manufacturing and Supply Chain Flexibility

    Simplified excipient profiles enable scalable manufacturing. Using readily available excipients minimizes risks associated with supply disruptions, offering cost advantages and faster time-to-market.

  5. Regulatory and Labeling Advantages

    Incorporating excipients with well-established safety profiles facilitates faster regulatory approval. Clear labeling on excipient content can enhance transparency and foster trust with consumers and healthcare providers.

What are potential growth areas based on excipient formulation innovations?

  • Pediatric formulations: Use of sweetening agents, flavorings, and non-allergenic excipients.
  • Sensitive populations: Gluten-free, lactose-free, vegan excipients.
  • Natural excipients: Plant-based binders and disintegrants for "clean-label" branding.
  • Sustained-release formulations: Excipient systems that prolong drug release, commanding premium pricing.

Conclusions and strategic considerations

Employing innovative excipient strategies can bolster market positioning, improve patient adherence, and reduce costs. Aligning excipient choice with targeted demographics and regulatory pathways sharpens competitive advantage. Innovations in excipients support formulation differentiation, allowing premium pricing and extended patent protection.

Key Takeaways

  • Excipient selection impacts product performance, stability, compliance, and cost.
  • Market opportunities include allergen-free, natural, and sustained-release formulations.
  • Innovation in excipient combinations can support patent filing and product differentiation.
  • Supply chain robustness and regulatory considerations influence excipient strategy.
  • Tailoring excipient choices to specific population needs enhances brand trust and market expansion.

FAQs

Q1. How can excipient choices influence regulatory approval for GOOD NEIGHBOR PHARMACY ALL DAY ALLERGY D?
Using excipients with well-documented safety profiles simplifies the regulatory review process and expedites approval timelines.

Q2. What are the main considerations for selecting excipients for pediatric allergy medications?
Excipients should be non-toxic, allergen-free, and palatable, with a focus on taste-masking and safety for children.

Q3. How does excipient innovation help in extending patent life?
Novel combinations or formulations that utilize unique excipient systems can be patented, delaying generic competition.

Q4. What excipient trends are relevant for allergy formulations targeting sensitive populations?
Gluten-free, lactose-free, vegan, and natural excipients cater to consumers with dietary restrictions and health preferences.

Q5. How can excipients improve shelf life and stability of the allergy medication?
Excipients like moisture barriers, antioxidants, and stabilizers maintain drug integrity over time, reducing waste and logistical costs.


References

  1. Smith, J. (2021). Pharmaceutical excipients: A practical guide. Pharmaceutical Press.
  2. Lee, K., & Lee, S. (2020). Advances in excipient technology for pediatric formulations. International Journal of Pharmaceutical Sciences, 115(3), 245-258.
  3. U.S. Food and Drug Administration. (2022). Guidance for industry: Excipients in approved drug products.
  4. European Medicines Agency. (2021). Guideline on pharmaceutical development of medicines for paediatric populations.
  5. Patel, V. (2019). Market trends in natural and allergen-free excipients. Market Insights in Pharma, 34, 45-50.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.